PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27873490-8	2017	Reversible EGFR-TKI (gefitinib) resensitized cancer cells to RET inhibitors, even in the presence of EGF.	Gefitinib	21-30	ret proto-oncogene	Homo sapiens	61-64